PARP1 and cancer: The observation that the role of BRCA1 in promotion of SCE following replication fork collapse is more profound in cells depleted of ATR provides the possibility of sensitizing cancer cells without functional of BRCA1 to PARP inhibitors by ATR inhibitors.